Lupin appoints Johnny Mikell as Global Head of Quality

Drug firm Lupin on Thursday said it has appointed Johnny Mikell as President and Global Head of Quality of the company.

He will be based out of the company's US offices and will lead the quality function globally and, will help steer the company towards enhanced standards of quality and compliance, Lupin said in a BSE filing.

Mikell is a very competent quality leader and brings to Lupin over 35 years of rich pharmaceutical industry experience and expertise, it added.

"We are delighted to have Johnny joining our leadership team. We have a strong quality and compliance team and having Johnny at the helm will help us achieve our near-term goal of ensuring that our sites are compliant and long-term goal of being the best when it comes to quality and compliance," Lupin MD Nilesh Gupta said.

In his most recent engagement, Johnny was the global head of quality and compliance at Apotex, the statement said.

He has significant experience in global quality operations and compliance in the generics, branded and active pharmaceutical ingredient (API) segments, it added.

Shares of Lupin Ltd closed at Rs 701.05 per scrip on the BSE, down 0.31 per cent from its previous close.